Public Health Archives - Page 3 of 34

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

October 7, 2025

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

October 6, 2025

Monash University Launches Boston Hub to Accelerate Global Biotech Collaborations and Licensing

October 2, 2025

THIS WEEK'S STORIES

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

October 7, 2025

Twist Bioscience Highlights Role in Science Publication on Biosecurity Screening for AI-Assisted Protein Design

October 3, 2025

Astria Therapeutics Begins Enrolling European Patients in Phase 3 ALPHA-ORBIT Trial for Hereditary Angioedema

October 2, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

New Survey Highlights Ongoing Misconceptions About Mammograms in Breast Cancer Awareness Month

Survey Finds Broad Global Support for Smoke-Free Alternatives to Reduce Smoking

Survey Finds Real-Time CPR Coaching Boosts Confidence in Cardiac Emergencies

MoldCo Raises $8 Million to Expand Mold Detox Platform and Tackle Widespread Health Crisis

Phreesia Partners with Sesame Workshop to Promote Children’s Health Through Sesame Street

Most Read

Gunze Medical Signs Exclusive Distribution Agreement with HistoSonics for Noninvasive Histotripsy Platform in Japan

Haleon Partners with Salesforce to Enhance Global Customer Engagement Using AI-Powered Life Sciences Cloud

Mikael Dolsten, M.D., Ph.D., Named Chairman of TRIO Pharmaceuticals

Jefferson River Capital Launches Jefferson Life Sciences, a New Early-Stage Investment Firm Focused on Human Health Innovation

EDITOR PICKS

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

Monash University Launches Boston Hub to Accelerate Global Biotech Collaborations and Licensing

THIS WEEK'S STORIES

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

Twist Bioscience Highlights Role in Science Publication on Biosecurity Screening for AI-Assisted Protein Design

Astria Therapeutics Begins Enrolling European Patients in Phase 3 ALPHA-ORBIT Trial for Hereditary Angioedema

POPULAR CATEGORY

ABOUT US

FOLLOW US